AMBARELLA, INC.

AMBA

CIK 0001280263 · Quarterly mode · latest period FY2026 (Q4) (ending 2026-01-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q4)

Revenue
$101M
↑+20.1% +$17Mvs FY2025 (Q4)
Gross Profit
$59M
↑+16.9% +$9Mvs FY2025 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
50/100
  • Profitability
    0ROIC -11.3% (10% = solid, 20%+ = moat)
  • Liquidity
    90Current Ratio 2.31 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    25Asset Turnover 0.53x (1.0+ = capital-efficient)
  • Growth
    84Revenue YoY +20.1% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -15.0% · trend +30.7pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project AMBA's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 25.9%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$45.31
Total enterprise IV
$1.93B
Diluted shares
0.04B
Terminal PV
$1.50B (78% of total)
Year-5 FCF
$177M
YearProjected FCFDiscounted PV
+1$73M$66M
+2$91M$75M
+3$113M$85M
+4$142M$97M
+5$177M$110M
Terminal$2.42B$1.50B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$16M
investment in PP&E
Stock buybacks (TTM)
$1M
share count reduction
Stock-based comp (TTM)
$98M
non-cash dilution

Balance sheet · 2026-01-31

latest filed snapshot
Total assets
$799M
everything owned
Total liabilities
$204M
everything owed
Stockholders' equity
$595M
shareholder claim

Recent performance · 60 quarters

Revenue↑+20.1% +$17M
$101M
Net Income↑+37.2% +$9M
$-15M
Free Cash Flow↓-29.5% -$6M
$15M
Operating Margin↑+15.9pts
-15.0%

Drill down